Tirzepatide pilot trial explores colorectal cancer risk biomarkers and prevention feasibility
Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors
Abstract
A Phase 1 pilot trial is underway to assess tirzepatide's effects on colorectal cancer risk biomarkers and evaluate the feasibility of precision prevention.
TitrateLab articles covering Tirzepatide
Written by TitrateLab, separately from the study summarized above.
